The Diabetes Medication Adherence Promotion Intervention Trial

Completed · Not applicable

Conditions studied: Diabetes Mellitus, Type 2

In brief

A significant percentage of persons with diabetes fail to properly take their prescribed oral hypoglycemic agents (OHA) and insulin. Non-adherence to medications among diabetes patients is associated with poor health outcomes including suboptimal glycemic control, diabetes-related complications, elevated health costs and increased risk of hospitalization and mortality. Given the substantial impact of non-compliance on the health of patients, prior studies have sought to draw links between medication adherence and patient factors. Research shows that web-based interventions that support patients' medication-related knowledge, motivation and skills effectively improve compliance. The purpose of this study is to evaluate the impact of a patient web portal (PWP)-delivered medication adherence promotion intervention on medication adherence and glycemic control among patients with type 2 diabetes (T2DM). The intervention aims to (1) increase self-reported adherence to glucose lowering agents (GLAs) and (2) improve diabetes health outcomes (decreased HbA1c) by increasing patients' medication adherence-related knowledge, motivation and skills. This research will greatly enhance the investigators' understanding of medicine compliance and the factors that effectively improve adherence among high-risk patients with diabetes. Knowledge gained from this work may inform future internet-based patient portals that support disease management and medication adherence more broadly.

Key facts

Study ID

NCT02458495

Run by

Vanderbilt University

People needed

151

Starts

2015-08-01

Expected to finish

2016-09-01

Last updated by the study team

2016-11-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults 18 years and older (to be confirmed by electronic health record)
• Individuals who have received a diagnosis for type 2 diabetes mellitus (T2DM)
• Enrolled as a patient in the Vanderbilt APPC or the Eskind Diabetes Clinic
• Registered My Health at Vanderbilt user
• Recent A1c of 7.0 or greater
• Individuals currently being treated with oral and/or injectable diabetes medication (to be confirmed through electronic health record)

You may not qualify if…

• Non-English speakers (determined by a trained research assistant)
• Individuals with a severe hearing or visual impairment (determined subjectively by a trained research assistant)
• Individuals with delirium or a severe cognitive impairment (determined by a lack of orientation to person, place, and time)
• Individuals who report a caregiver administers their diabetes medications
• Individuals who report they do not have a mobile phone or computer with internet access
• Individuals unwilling and/or unable to provide written informed consent

Where it is running

• Vanderbilt University Medical Center — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.